Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial by SILVERMAN, Michael H, STRAND, Vibeke, CASPI, Dan, TISHLER, Moshe, LANGEVITZ, Pnina, RUBINOW, Alan, FRIEDMAN, Joshua, GREEN, Lesly, TANAY, Amir, OCHAION, Avivit, COHEN, Shira, KERNS, William D, MARKOVITS, Doron, COHN, Ilan, FISHMAN-FURMAN, Sari, FARBSTEIN, Motti, SARA BAR YEHUDA, FISHMAN, Pnina, NAHIR, Menachem, REITBLAT, Tatiana, MOLAD, Yair, ROSNER, Itzhak, ROZENBAUM, Michael, MADER, Reuven, ADAWI, Muhamad

Get full text

CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open‐Label, Dose‐Escalation Study by Stemmer, Salomon M., Benjaminov, Ofer, Medalia, Gal, Ciuraru, Noab B., Silverman, Michael H., Bar‐Yehuda, Sara, Fishman, Sari, Harpaz, Zivit, Farbstein, Motti, Cohen, Shira, Patoka, Renana, Singer, Barak, Kerns, William D., Fishman, Pnina

Get full text

Therapeutic Effect of Oral CF101 in Patients with Rheumatoid Arthritis: A Randomized, Double-blind, Placebo-controlled Phase II Study by Stoilov, Rumen M

Get full text

Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3 adenosine receptor expression by Ochaion, Avivit, Bar-Yehuda, Sara, Cohn, Shira, Del Valle, Luis, Perez-Liz, Georginia, Madi, Lea, Barer, Faina, Farbstein, Motti, Fishman-Furman, Sari, Reitblat, Tatiana, Reitblat, Alexander, Amital, Howard, Levi, Yair, Molad, Yair, Mader, Reuven, Tishler, Moshe, Langevitz, Pnina, Zabutti, Alexander, Fishman, Pnina

Get full text

Methotrexate enhances the anti-inflammatory effect of CF101 via up-regulation of the A3adenosine receptor expression by Ochaion, Avivit, Bar-Yehuda, Sara, Cohn, Shira, Del Valle, Luis, Perez-Liz, Georginia, Madi, Lea, Barer, Faina, Farbstein, Motti, Fishman-Furman, Sari, Reitblat, Tatiana, Reitblat, Alexander, Amital, Howard, Levi, Yair, Molad, Yair, Mader, Reuven, Tishler, Moshe, Langevitz, Pnina, Zabutti, Alexander, Fishman, Pnina

Get full text